Global Conference on Gynecology & Women's Health, April 20-22, 2023 | Orlando, USA |

For professionals active in Obstetrics and Gynecology in general and Autism in particular, it is suggested that they connect or attend the Magnus Conference in April of 2023. in Orlando, Florida.

Today it be my privilege to review our studies on the putative cause and prevention of AUTISM, as elucidated in our research at Hadassah Hospital of Jerusalem, Israel over the last 10 years (see publication list).  Such studies have resulted in several published articles, books, and chapters (see list) on processes in the female body.  This project was aided by the in depth knowledge of human reproduction and physiologic development in the fetus and neonate.  Of special importance was relating the biochemical trend modifications of insulin-like growth factor-1 (IGF-1), as affected by interleukin changes in mothers and their offspring during reproduction and neonatal development.  In particular, these studies have reinforced the protective value of human breast feeding to the offspring, especially where maternal fever (with Covid-19, for example) had complicated the biochemical/biophysical development of the antepartum fetus.

Global Conference on Gynecology & Women's Health | Orlando, USA | April 20-22, 2023

Dear attendees of the global conference on Gynecology & Women’s Health. It is my honor and great pleasure to write a few sentences to welcome you. Today, the progress in the biotechnology era is the most advanced in the history. Many opportunities have become available, which are helpful in addressing various problems that need urgent attendance.

Only in the biomedical field, we have seen many developments, from gene sequencing to gene editing, gene therapy, regenerative medical therapy, personalized drugs, diagnosis of rare disease, wearable medical devices, robotic surgeries and artificial intelligence. Biomedical engineering is a new discipline and has developed significantly in a few years to address multiple fields from nanoengineering, synthetic biology and telehealth to medical imaging and tissue engineering. Multidisciplinary collaboration plays a critical role in addressing issues and making our world a better place for us and the future generation.

Global Conference on Gynecology & Women's Health | April 20-22 | Orlando, USA

“ Since the Pregnancy Mortality Surveillance System was implemented, the number of reported pregnancy-related deaths in the United States steadily increased from 7.2 deaths per 100,000 live births in 1987 to 17.3 deaths per 100,000 live births in 2018. 

The reasons for the overall increase in pregnancy-related mortality are unclear. Identification of pregnancy-related deaths has improved over time due to the use of computerized data linkages between death records and birth and fetal death records by states, changes in the way causes of death are coded, and the addition of a pregnancy checkbox to death records. However, errors in reported pregnancy status on death records have been described, potentially leading to overestimation of the number of pregnancy-related deaths.1 Whether the actual risk of a woman dying from pregnancy-related causes has increased is unclear, and in recent years, the pregnancy-related mortality ratios have been relatively stable.

This International meeting will highlight many aspects of obstetrics and gynaecology, but this worrying information on the alleged increased mortality of pregnancy related deaths in USA is enough to justify any effort to offer the best for new mother in USA and in the world.”